Biotech News

Materialise Reports First Quarter 2026 Results

Materialise (MTLS)Materialise2026-06-25 13:46 ESTEarnings

Materialise transfers eyewear business to its management team Regulated information 1 LEUVEN, Belgium --(BUSINESS WIRE)--May 7, 2026-- Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services,

Open original release

Related news

Materialise

Materialise is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States